119 related articles for article (PubMed ID: 33713637)
1. Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women.
Bertozzi-Matheus M; Bueno-Pereira TO; Viana-Mattioli S; Carlström M; Cavalli RC; Sandrim VC
Clin Biochem; 2021 Jun; 92():25-33. PubMed ID: 33713637
[TBL] [Abstract][Full Text] [Related]
2.
Luizon MR; Pinto-Souza CC; Coeli-Lacchini F; Lacchini R; Cavalli RC; Sandrim VC
Pharmacogenomics; 2022 Aug; 23(13):713-722. PubMed ID: 35971863
[No Abstract] [Full Text] [Related]
3. Influence of the AT(2) receptor on the L-arginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia.
González-Garrido Chem JA; Olivares-Corichi IM; Tovar-Rodriguez JM; Hernández-Santana NA; Méndez-Bolaina E; Ceballos-Reyes GM; García-Sánchez JR
J Hum Hypertens; 2013 Jun; 27(6):355-61. PubMed ID: 23223087
[TBL] [Abstract][Full Text] [Related]
4. Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia.
Pinto-Souza CC; Coeli-Lacchini F; Luizon MR; Cavalli RC; Lacchini R; Sandrim VC
Nitric Oxide; 2021 May; 109-110():20-25. PubMed ID: 33676021
[TBL] [Abstract][Full Text] [Related]
5. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension.
Sandrim VC; Palei AC; Luizon MR; Izidoro-Toledo TC; Cavalli RC; Tanus-Santos JE
Pharmacogenomics J; 2010 Feb; 10(1):40-5. PubMed ID: 19704415
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of pregnancy-associated granulocytic myeloid-derived suppressor cell expansion and arginase-1 production in preeclampsia.
Wang Y; Liu Y; Shu C; Wan J; Shan Y; Zhi X; Sun L; Yi H; Yang YG; He J
J Reprod Immunol; 2018 Jun; 127():48-54. PubMed ID: 29763854
[TBL] [Abstract][Full Text] [Related]
7. Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia.
Sankaralingam S; Xu H; Davidge ST
Cardiovasc Res; 2010 Jan; 85(1):194-203. PubMed ID: 19684035
[TBL] [Abstract][Full Text] [Related]
8. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Luizon MR; Palei ACT; Belo VA; Amaral LM; Lacchini R; Duarte G; Cavalli RC; Sandrim VC; Tanus-Santos JE
Pharmacogenomics J; 2017 Oct; 17(5):427-434. PubMed ID: 27168100
[TBL] [Abstract][Full Text] [Related]
9. Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women.
Bernardi F; Constantino L; Machado R; Petronilho F; Dal-Pizzol F
J Obstet Gynaecol Res; 2008 Dec; 34(6):957-63. PubMed ID: 19012693
[TBL] [Abstract][Full Text] [Related]
10. Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in the plasma and placentae from preeclamptic patients.
Bernardi FC; Vuolo F; Petronilho F; Michels M; Ritter C; Dal-Pizzol F
An Acad Bras Cienc; 2015; 87(2):713-9. PubMed ID: 25993363
[TBL] [Abstract][Full Text] [Related]
11.
Pereira DA; Sandrim VC; Palei AC; Amaral LM; Belo VA; Lacchini R; Cavalli RC; Tanus-Santos JE; Luizon MR
Pharmacogenomics; 2021 Jun; 22(8):451-464. PubMed ID: 33944612
[No Abstract] [Full Text] [Related]
12. Red blood cells from patients with pre-eclampsia induce endothelial dysfunction.
McCann Haworth SM; Zhuge Z; Nihlén C; Von Rosen MF; Weitzberg E; Lundberg JO; Krmar RT; Nasiell J; Carlström M
J Hypertens; 2021 Aug; 39(8):1628-1641. PubMed ID: 33657586
[TBL] [Abstract][Full Text] [Related]
13. [Genetic variants of endothelial nitric synthase in gestational hypertension and preeclampsia].
Perlik M; Seremak-Mrozikiewicz A; Barlik M; Kurzawińska G; Kraśnik W; Drews K
Ginekol Pol; 2012 Sep; 83(9):652-9. PubMed ID: 23342892
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.
Luizon MR; Palei AC; Cavalli RC; Sandrim VC
Pharmacogenomics; 2017 Apr; 18(6):571-583. PubMed ID: 28358601
[TBL] [Abstract][Full Text] [Related]
15. L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia.
Pimentel AM; Pereira NR; Costa CA; Mann GE; Cordeiro VS; de Moura RS; Brunini TM; Mendes-Ribeiro AC; Resende AC
Hypertens Res; 2013 Sep; 36(9):783-8. PubMed ID: 23575380
[TBL] [Abstract][Full Text] [Related]
16. The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy.
Ngene NC; Moodley J; Naicker T
PLoS One; 2019; 14(4):e0215807. PubMed ID: 31022243
[TBL] [Abstract][Full Text] [Related]
17. Arginase controls soluble vascular endothelial growth factor receptor 1 (sFlt1) to maintain pregnancy homeostasis.
Tanaka H; Kumasawa K; Kakigano A; Mimura K; Endo M; Tomimatsu T; Kimura T
Biochem Biophys Res Commun; 2018 May; 499(2):150-155. PubMed ID: 29548823
[TBL] [Abstract][Full Text] [Related]
18. Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and pre-eclampsia.
Boccardo P; Soregaroli M; Aiello S; Noris M; Donadelli R; Lojacono A; Benigni A
Br J Obstet Gynaecol; 1996 Sep; 103(9):879-86. PubMed ID: 8813307
[TBL] [Abstract][Full Text] [Related]
19. Is there a link between endothelial dysfunction, coagulation activation and nitric oxide synthesis in preeclampsia?
Dusse LM; Alpoim PN; Lwaleed BA; de Sousa LP; Carvalho Md; Gomes KB
Clin Chim Acta; 2013 Jan; 415():226-9. PubMed ID: 23089074
[TBL] [Abstract][Full Text] [Related]
20. Rheological parameters in the umbilical cord blood in moderate and severe forms of preeclampsia.
Csorba R; Yilmaz A; Tsikouras P; Wieg C; Teichmann A; von Tempelhoff GF
Clin Hemorheol Microcirc; 2013 Jan; 55(4):391-401. PubMed ID: 24113499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
